NSO-04 Evaluation of Clinical Outcomes and Toxicities in Multiple Myeloma Patients Receiving Commercial Talquetamab
Lu, Rebecca, Chen, Jessica, Ow, Karla, Hildebrandt, Michelle, Huen, Auris, Cardoso, Richard, Chambers, Mark, Abreu, Michelly, Cuellar, Elizabeth, Ighovoyivwi, Efe, Knight, Sarah, Santiago, Minifrida, Savoie, Cecilia, Varghese, Jaimole, Zachariah, Annie, Becnel, Melody, Gaballa, Mahmoud, Orlowski, Robert, Patel, Krina, Pasvolsky, Oren, Thomas, Sheeba, Ye, Jing Christine, Weber, Donna, Lee, Hans, Richards, Tiffany
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
Strati, Paolo, Pasvolsky, Oren, Feng, Lei, Xu, Guofan, Tewari, Sanjit O., Varghese, Jaimole, Ow, Karla, Santiago, Minifrida, Al Zaki, Ajlan, Jallouk, Andrew, Neelapu, Sattva S., Kebriaei, Partow, Shpall, Elizabeth J., Ahmed, Sairah
Published in Blood advances (13.06.2023)
Published in Blood advances (13.06.2023)
Get full text
Journal Article